Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Cabergoline Tablets bulk supplier for pharma manufacturers

Cabergoline Tablets 0.25 mg, 0.5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg

Reference Brands: Dostinex (US/EU)

Category: Antipsychotropic Drugs

Cabergoline Tablet is a medicine that is used for the treatment of Moderate To Severe Labor Pain, Moderate To Severe Surgery Pain and other conditions. Cabergoline Tablet contains Cabergoline as an active ingredient. Cabergoline Tablet works by blocking certain nerves in brain thus relieving pain.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cabergoline Tablets? List it or send an offer →

Product Description: Cabergoline Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Moderate To Severe Labor Pain · Moderate To Severe Surgery Pain

Cabergoline Tablets — third party manufacturing & bulk supply

Cabergoline Tablets 0.25 mg, 0.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cabergoline Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cabergoline Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cabergoline Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cabergoline Tablets is listed as Tablets in 0.25 mg, 0.5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cabergoline Tablets is referenced against Dostinex (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Levodopa Carbidopa Tablets

Strength:
110mg,125mg,275mg

Form: Tablets

Reference Brands:

View Details
Pramipexole 4.5Mg Tablets

Strength:
0.125 mg, 0.25 mg, 0.5 mg, 1 mg

Form: Tablets

Reference Brands: Mirapex (USA)

View Details
Chlordiazepoxide Tablets

Strength:
10mg, 25mg

Form: Tablets

Reference Brands: Librium (USA/EU), Risolid (India)

View Details
Clobazam Tablets

Strength:
5mg, 10mg, 15mg

Form: Tablets

Reference Brands: Onfi (US), Frisium (EU)

View Details
Sertraline

Strength:
20 mg/mL

Form: Oral Solution

Reference Brands: Zoloft(US & EU)

View Details
Olanzapine

Strength:
2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg

Form: Tablets/ODT

Reference Brands: Zyprexa, Zyprexa Zydis(US)

View Details
Olanzapine Injection

Strength:
210 mg, 300 mg, 405 mg per vial (monthly dosing)

Form: Depot Injection

Reference Brands: Zyprexa Relprevv (Depot Injection)

View Details
Naloxone

Strength:
0.4 mg/mL, 1 mg/mL in 1 mL ampoules or vials

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) Injection

Reference Brands: Narcan & Genereics

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us